Elanco Animal Health Inc. received a second information request from the U.S. Federal Trade Commission regarding its $7.6 billion acquisition of Bayer AG's animal health business.
Greenfield, Ind.-based Elanco said the request was part of the standard regulatory review process under the Hart-Scott-Rodino Act. The request essentially extends the waiting period imposed under the antitrust act for 30 days after the companies involved have provided the information sought.
The transaction, which is subject to regulatory approval and closing conditions, is still expected to close in mid-2020, according to Elanco.
Elanco has previously said the deal will double its companion animal business, advance the company's intentional portfolio mix transformation and create a balance between its food animal and companion animal segments.